| 000 | 01691 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517010424.0 | ||
| 264 | 0 | _c20151103 | |
| 008 | 201511s 0 0 eng d | ||
| 022 | _a1473-5741 | ||
| 024 | 7 |
_a10.1097/CAD.0000000000000195 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aXu, Chaochao | |
| 245 | 0 | 0 |
_aThe therapeutic potential of a novel non-ATP-competitive fibroblast growth factor receptor 1 inhibitor on gastric cancer. _h[electronic resource] |
| 260 |
_bAnti-cancer drugs _cApr 2015 |
||
| 300 |
_a379-87 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCell Line, Tumor _xdrug effects |
| 650 | 0 | 4 |
_aCell Movement _xdrug effects |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aDown-Regulation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMasoprocol _xpharmacology |
| 650 | 0 | 4 | _aNeoplasm Invasiveness |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aReceptor, Fibroblast Growth Factor, Type 1 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aStomach Neoplasms _xdrug therapy |
| 700 | 1 | _aLi, Wulan | |
| 700 | 1 | _aQiu, Peihong | |
| 700 | 1 | _aXia, Yiqun | |
| 700 | 1 | _aDu, Xiaojing | |
| 700 | 1 | _aWang, Fen | |
| 700 | 1 | _aShen, Lailai | |
| 700 | 1 | _aChen, Qiuxiang | |
| 700 | 1 | _aZhao, Yunjie | |
| 700 | 1 | _aJin, Rong | |
| 700 | 1 | _aWu, Jianzhang | |
| 700 | 1 | _aLiang, Guang | |
| 700 | 1 | _aLi, Xiaokun | |
| 773 | 0 |
_tAnti-cancer drugs _gvol. 26 _gno. 4 _gp. 379-87 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/CAD.0000000000000195 _zAvailable from publisher's website |
| 999 |
_c24470207 _d24470207 |
||